RE: Think of BRH investment case27 May 2020 10:48
True but AVCT was worth 10% of current market cap pre-COVID so it's fair to say that a large chunk of the 400 odd million is directly attributable to a COVID test (oh and they also stumbled across a therapy/treatment too which has surely added to value there!), point is yes £7m is way way behind if these guys here can get their technology to a test product. Rampers spouting utter uninformed wishful thinking by the looks of it, wish people would just be honest, the signs that are here are that the price has tanked considerably, there's no sign of a huge rise but there is 'potential', if the latter is what people talked about then fair enough. Hopefully that's a balanced enough view for you Wolvesey! :-P